Patents by Inventor B. Naidu

B. Naidu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds Useful in HIV Therapy
    Publication number: 20230151049
    Abstract: The invention relates to compounds of Formula (I), salts thereof, pharmaceutical compositions thereof, as well as methods of treating or preventing HIV in subjects.
    Type: Application
    Filed: March 18, 2021
    Publication date: May 18, 2023
    Applicant: VIIV HEALTHCARE COMPANY
    Inventor: Namasimhulu B. NAIDU
  • HIV integrase inhibitors
    Publication number: 20070111984
    Abstract: The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
    Type: Application
    Filed: October 31, 2006
    Publication date: May 17, 2007
    Inventors: B. Naidu, Yasutsugu Ueda, John Matiskella, Michael Walker, Jacques Banville, Francis Beaulieu, Carl Ouellet, Serge Plamondon
  • HIV integrase inhibitors
    Publication number: 20070111985
    Abstract: The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
    Type: Application
    Filed: November 10, 2006
    Publication date: May 17, 2007
    Inventors: B. Naidu, Margaret Sorenson, Yasutsugu Ueda, John Matiskella, Michael Walker
  • Bicyclic heterocycles as HIV integrase inhibitors
    Publication number: 20060276466
    Abstract: The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
    Type: Application
    Filed: August 16, 2006
    Publication date: December 7, 2006
    Inventors: B. Naidu, Jacques Banville, Francis Beaulieu, Timothy Connolly, Mark Krystal, John Matiskella, Carl Ouellet, Serge Plamondon, Roger Remillard, Margaret Sorenson, Yasutsugu Ueda, Michael Walker
  • HIV integrase inhibitors
    Patent number: 7135467
    Abstract: Compounds useful for treating HIV are disclosed having the general formula wherein R1, R2, and B are as defined in the specification. Compositions containing the compounds and methods for using the compounds to inhibit HIV are also disclosed.
    Type: Grant
    Filed: January 12, 2004
    Date of Patent: November 14, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Michael A. Walker, Hatice Belgin Gulgeze, Narasimhulu B. Naidu, Margaret E. Sorenson, Yasutsugu Ueda, John Matiskella
  • Bicyclic heterocycles as HIV integrase inhibitors
    Publication number: 20060199956
    Abstract: The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
    Type: Application
    Filed: November 29, 2005
    Publication date: September 7, 2006
    Inventors: B. Naidu, Jacques Banville, Francis Beaulieu, Timothy Connolly, Mark Krystal, John Matiskella, Carl Ouellet, Serge Plamondon, Roger Remillard, Margaret Sorenson, Yasutsugu Ueda, Michael Walker
  • HIV integrase inhibitors: cyclic pyrimidinone compounds
    Publication number: 20060106007
    Abstract: The invention encompasses a series of pyrimidinone compounds which inhibit HIV integrase and thereby prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses intermediates useful for making the pyrimidone compounds. Additionally, pharmaceutical compositions and methods for treating those infected with HIV are encompassed.
    Type: Application
    Filed: November 14, 2005
    Publication date: May 18, 2006
    Inventors: B. Naidu, Timothy Connolly, Yasutsugu Ueda
  • Bicyclic heterocycles as HIV integrase inhibitors
    Publication number: 20050267105
    Abstract: The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
    Type: Application
    Filed: May 11, 2005
    Publication date: December 1, 2005
    Inventors: B. Naidu, Jacques Banville, Francis Beaulieu, Timothy Connolly, Mark Krystal, John Matiskella, Carl Ouellet, Serge Plamondon, Roger Remillard, Margaret Sorenson, Yasutsugu Ueda, Michael Walker
  • Bicyclic heterocycles as HIV integrase inhibitors
    Publication number: 20050267132
    Abstract: The invention encompasses a series cyclic bicyclic heterocyclic compounds of Formula I which are inhibitors of HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
    Type: Application
    Filed: May 26, 2005
    Publication date: December 1, 2005
    Inventors: Jacques Banville, Gilles Bouthillier, B. Naidu, Roger Remillard, Michael Walker
  • Bicyclic heterocycles as HIV integrase inhibitors
    Publication number: 20050267131
    Abstract: The invention encompasses a series cyclic bicyclic heterocyclic compounds of Formula I which are inhibitors of HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
    Type: Application
    Filed: May 26, 2005
    Publication date: December 1, 2005
    Inventors: B. Naidu, Jacques Banville, John Matiskella, Serge Plamondon, Yasutsugu Ueda
  • HIV integrase inhibitors
    Publication number: 20050261322
    Abstract: Compounds of the present disclosure are spirocycle-substituted pyrimidinecarboxamides. Also disclosed are pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating HIV infection and AIDS.
    Type: Application
    Filed: May 12, 2005
    Publication date: November 24, 2005
    Inventors: B. Naidu, Margaret Sorenson
  • HIV integrase inhibitors: cyclic pyrimidinone compounds
    Publication number: 20050256109
    Abstract: The invention encompasses a series of pyrimidinone compounds which inhibit HIV integrase and thereby prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses intermediates useful for making the pyrimidone compounds. Additionally, pharmaceutical compositions and methods for treating those infected with HIV are encompassed.
    Type: Application
    Filed: April 20, 2005
    Publication date: November 17, 2005
    Inventor: B. Naidu
  • HIV integrase inhibitors
    Publication number: 20040204498
    Abstract: Compounds useful for treating HIV are disclosed having the general formula 1
    Type: Application
    Filed: January 12, 2004
    Publication date: October 14, 2004
    Inventors: Michael A. Walker, Hatice Belgin Gulgeze, Narasimhulu B. Naidu, Margaret E. Sorenson, Yasutsugu Ueda, John Matiskella